Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation.
Hong KW, Kim KY, Shin HK, Lee JH, Choi JM, Kwak YG, Kim CD, Lee WS, Rhim BY. Hong KW, et al. Among authors: kim cd, kim ky. J Pharmacol Exp Ther. 2003 Sep;306(3):1182-90. doi: 10.1124/jpet.103.052365. Epub 2003 Jun 13. J Pharmacol Exp Ther. 2003. PMID: 12807996
Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
Kim KY, Shin HK, Lee JH, Kim CD, Lee WS, Rhim BY, Shin YW, Hong KW. Kim KY, et al. Among authors: kim cd. J Pharmacol Exp Ther. 2004 Jan;308(1):97-104. doi: 10.1124/jpet.103.058768. Epub 2003 Oct 20. J Pharmacol Exp Ther. 2004. PMID: 14569058
Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation.
Park SY, Lee JH, Kim YK, Kim CD, Rhim BY, Lee WS, Hong KW. Park SY, et al. Among authors: kim cd, kim yk. J Pharmacol Exp Ther. 2005 Mar;312(3):1241-8. doi: 10.1124/jpet.104.077826. Epub 2004 Nov 3. J Pharmacol Exp Ther. 2005. PMID: 15525793
140 results